These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 17971765)

  • 1. [Genetically engineered mice: mouse models for cancer research].
    Szymańska H
    Postepy Hig Med Dosw (Online); 2007 Oct; 61():639-45. PubMed ID: 17971765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application and recent advances of laboratory mouse in human cancer research].
    Liu EQ; Kitajima S; Morimoto M
    Ai Zheng; 2005 Feb; 24(2):249-54. PubMed ID: 15694046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling cancer using genetically engineered mice.
    Stiedl P; Grabner B; Zboray K; Bogner E; Casanova E
    Methods Mol Biol; 2015; 1267():3-18. PubMed ID: 25636462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering the mouse genome to model human disease for drug discovery.
    Koentgen F; Suess G; Naf D
    Methods Mol Biol; 2010; 602():55-77. PubMed ID: 20012392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee.
    Shappell SB; Thomas GV; Roberts RL; Herbert R; Ittmann MM; Rubin MA; Humphrey PA; Sundberg JP; Rozengurt N; Barrios R; Ward JM; Cardiff RD
    Cancer Res; 2004 Mar; 64(6):2270-305. PubMed ID: 15026373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technologically advanced cancer modeling in mice.
    Tuveson DA; Jacks T
    Curr Opin Genet Dev; 2002 Feb; 12(1):105-10. PubMed ID: 11790563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically engineered mouse models for lung cancer.
    Kwak I; Tsai SY; DeMayo FJ
    Annu Rev Physiol; 2004; 66():647-63. PubMed ID: 14977417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse models of human familial cancer syndromes.
    Ward JM; Devor-Henneman DE
    Toxicol Pathol; 2004; 32 Suppl 1():90-8. PubMed ID: 15209408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models.
    Varticovski L; Hollingshead MG; Robles AI; Wu X; Cherry J; Munroe DJ; Lukes L; Anver MR; Carter JP; Borgel SD; Stotler H; Bonomi CA; Nunez NP; Hursting SD; Qiao W; Deng CX; Green JE; Hunter KW; Merlino G; Steeg PS; Wakefield LM; Barrett JC
    Clin Cancer Res; 2007 Apr; 13(7):2168-77. PubMed ID: 17404101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of genetically engineered mouse models of prostate cancer for nutrition and cancer chemoprevention research.
    Klein RD
    Mutat Res; 2005 Aug; 576(1-2):111-9. PubMed ID: 15885713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse phenogenomics, toolbox for functional annotation of human genome.
    Kim IY; Shin JH; Seong JK
    BMB Rep; 2010 Feb; 43(2):79-90. PubMed ID: 20193125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparative pathology of genetically engineered mouse models for neuroendocrine carcinomas of the lung.
    Gazdar AF; Savage TK; Johnson JE; Berns A; Sage J; Linnoila RI; MacPherson D; McFadden DG; Farago A; Jacks T; Travis WD; Brambilla E
    J Thorac Oncol; 2015 Apr; 10(4):553-64. PubMed ID: 25675280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum.
    Weiss WA; Israel M; Cobbs C; Holland E; James CD; Louis DN; Marks C; McClatchey AI; Roberts T; Van Dyke T; Wetmore C; Chiu IM; Giovannini M; Guha A; Higgins RJ; Marino S; Radovanovic I; Reilly K; Aldape K
    Oncogene; 2002 Oct; 21(49):7453-63. PubMed ID: 12386807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical in vitro models from genetically engineered mice for breast and colon cancer (Review).
    Telang N; Katdare M
    Oncol Rep; 2011 May; 25(5):1195-201. PubMed ID: 21399881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling cancer in mice.
    Jackson-Grusby L
    Oncogene; 2002 Aug; 21(35):5504-14. PubMed ID: 12154411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically engineered knock-in and conditional knock-in mouse models of cancer.
    Rappaport A; Johnson L
    Cold Spring Harb Protoc; 2014 Sep; 2014(9):897-911. PubMed ID: 25183823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis.
    Kasper S
    J Cell Biochem; 2005 Feb; 94(2):279-97. PubMed ID: 15565647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of mouse models for the analysis of human disease.
    Semsarian C
    Curr Protoc Hum Genet; 2002 May; Chapter 15():Unit 15.2. PubMed ID: 18428327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardized morphological phenotyping of mouse models of human diseases within the German Mouse Clinic.
    Mossbrugger I; Hoelzlwimmer G; Calzada-Wack J; Quintanilla-Martinez L
    Verh Dtsch Ges Pathol; 2007; 91():98-103. PubMed ID: 18314602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Making better transgenic models: conditional, temporal, and spatial approaches.
    Ristevski S
    Mol Biotechnol; 2005 Feb; 29(2):153-63. PubMed ID: 15699570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.